COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 1687: Articles 16861-16870  | Next

Persisting Salivary IgG against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
Alkharaan, H., Bayati, S., Hellstrom, C., Olsson, A., Lindahl, K., Bogdanovic, G., Aleman, S., Tsilingaridis, G., De Palma, P., Hober, S., Manberg, A., Nilsson, P., Pin, E., Sallberg Chen, M.
10.1101/2021.03.13.21253492 — Posted: 2021-03-15
Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020
Alcoba-Florez, J., Lorenzo-Salazar, J. M., Gil-Campesino, H., Inigo-Campos, A., Garcia-Martinez de Artola, D., Garcia-Olivares, V., Diez-Gil, O., Valenzuela-Fernandez, A., Ciuffeda, L., Gonzalez-Montelongo, R., Flores, C.
10.1101/2021.03.14.21253535 — Posted: 2021-03-15
The local and systemic response to SARS-CoV-2 infection in children and adults
Yoshida, M., Worlock, K. B., Huang, N., Lindeboom, R. G., Butler, C. R., Kumasaka, N., Dominguez Conde, C., Mamanova, L., Bolt, L., Richardson, L., Polanski, K., Madissoon, E., Barnes, J. L., Allen-Hyttinen, J., Kilich, E., Jones, B. C., de Wilton, A., Wilbrey-Clark, A., Sungnak, W., Prett, J. P., Prigmore, E., Yung, H., Mehta, P., Saleh, A., Saigal, A., Chu, V., Cohen, J. M., Cane, C., Iordanidou, A., Shibuya, S., Reuschl, A.-K., Argento, A. C., Wunderink, R. G., Smith, S. B., Poor, T. A., Gao, C. A., Dematte, J. E., NU SCRIPT Study Investigators, , Reynolds, G., Haniffa, M., Bowyer, G. S., Coates, M., Clatworthy, M. R., Calero-Nieto, F. J., Gottgens, B., O'Callaghan, C., Sebire, N. J., Jolly, C., de Coppi, P., Smith, C. M., Misharin, A. V., Janes, S. M., Teichmann, S. A., Nikolic, M. Z., Meyer, K. B.
10.1101/2021.03.09.21253012 — Posted: 2021-03-15
Impact of School Reopening on Pandemic Spread: A Case Study using an Agent-Based Model for COVID-19
Tatapudi, H. A., Das, T. K.
10.1101/2021.03.13.21253485 — Posted: 2021-03-15
Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
Kato, Y., Yamada, S., Nishiyama, K., Satsuka, A., Re, S., Tomokiyo, D., Lee, J. M., Tanaka, T., Nishimura, A., Yonemitsu, K., Asakura, H., Ibuki, Y., Imai, Y., Kamiya, N., Mizuguchi, K., Kusakabe, T., Kanda, Y., Nishida, M.
10.1101/2021.03.13.435221 — Posted: 2021-03-14
Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex
Malone, B., Chen, J., Wang, Q., Llewellyn, E., Choi, Y. J., Olinares, P. D. B., Cao, X., Hernandez, C., Eng, E. T., Chait, B. T., Shaw, D. E., Landick, R., Darst, S. A., Campbell, E. A.
10.1101/2021.03.13.435256 — Posted: 2021-03-14
COVID-19 Vaccine Acceptance and Hesitancy in Low and Middle Income Countries, and Implications for Messaging
Solis Arce, J. S., Warren, S. S., Meriggi, N. F., Scacco, A., McMurry, N., Voors, M., Syunyaev, G., Malik, A. A., Aboutajdine, S., Armand, A., Asad, S., Augsburg, B., Bancalari, A., Nyqvist, M. B., Borisova, E., Bosancianu, C. M., Cheema, A., Collins, E., Farooqui, A., Fracchia, M., Guariso, A., Hasanain, A., Kamwesigye, A., Kreps, S., Levine, M. E., Littman, R., Platas, M., Ramakrishna, V., Shapiro, J. N., Svensson, J., Vernot, C., Vicente, P., Weissinger, L., Zhang, B., Karlan, D., Callen, M., Teachout, M., Humphreys, M., Omer, S. B., Mobarak, A. M.
10.1101/2021.03.11.21253419 — Posted: 2021-03-13
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19
O'Donnell, M., Grinsztejn, B., Cummings, M., Justman, J., Lamb, M., Eckhardt, C., Phillip, N., Cheung, K., Abrams, D., Gupta, V., Diniz, M. P., Cardoso, S. W., Rajagopalan, K., Borden, S., Wolf, A., Bitan, Z., Meyer, B., Jacobson, S., Kantor, A., Mishra, N., Hod, E., Briese, T., Sidi, L. C., Wontakal, S., Hudson, K., Stotler, B., Lin, W.-H., Pilotto, J. H., Joao, E., Chauhan, L., Veloso, V., Schwartz, J., Stone, E., Dei Zotti, F., La Carpia, F., Shaz, B., Ferrara, S., Vizzoni, A., Spitalnick, S., Eisenberger, A., Lipin, W. I.
10.1101/2021.03.12.21253373 — Posted: 2021-03-13
Serum Vitamin D levels are associated with increased COVID-19 severity markers and mortality independent of visceral adiposity
Vanegas-Cedillo, P. E., Bello-Chavolla, O. Y., Ramirez-Pedraza, N., Rodriguez-Encinas, B., Perez-Carrion, C. I., Jasso-Avila, M. I., Hernandez-Juarez, D., Vargas-Vazquez, A., Antonio-Villa, N. E., Chapa-Ibarguengoitia, M., Ponce de Leon, A., Sifuentes-Osornio, J., Aguilar-Salinas, C. A., Mehta, R.
10.1101/2021.03.12.21253490 — Posted: 2021-03-13 Discussion: Onsite
Awake prone position in adult nonintubated patients with acute hypoxaemic respiratory failure secondary to COVID-19:A multi-centre feasibility randomized controlled trial
Jayakumar, D., Ramachandran, P., Rabindrarajan, E., Tirupakuzhi Vijayaraghavan, B., Nagarajan, R., Venkataraman, R.
10.1101/2021.03.13.21253499 — Posted: 2021-03-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).